The cell surface glycoprotein CDCP1 in cancer--insights, opportunities, and challenges.

IUBMB Life

Institute of Health and Biomedical Innovation and School of Life Sciences, Queensland University of Technology, Kelvin Grove, QLD, Australia.

Published: July 2009

In the last few years dysregulated expression of the cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) has been associated with several cancers and this cell surface molecule has been recognized both as a tumor marker and as a potential target to disrupt progression of cancer. Here we summarize what is known about CDCP1 including its structural features, expression in normal and cancerous tissues, and the in vitro experiments and studies in animal models that have provided the key insights into its potential role in tumor formation and metastasis in humans. We conclude by highlighting opportunities and challenges in targeting CDCP1 in cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1002/iub.198DOI Listing

Publication Analysis

Top Keywords

cell surface
12
surface glycoprotein
8
opportunities challenges
8
cdcp1
4
glycoprotein cdcp1
4
cdcp1 cancer--insights
4
cancer--insights opportunities
4
challenges years
4
years dysregulated
4
dysregulated expression
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!